Abstract:
The study involved 72 patients aged 20-65 years. Patients of the first group -35 patients received antisecretory therapy: pantoprazole 40 mg x 1 time daily during 14 days.
Patients of the second group -37 people, against the background of pantoprazole 40 mg x once a day for 14 days received rebagit 100 mg 3 times a day. The criteria for selection to both groups were the presence of erosive changes of gastric mucosa and fresh ulcers
on endoscopic examination
